Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Omnicom Adds National Healthcare Giant to Client Roster

August 18, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

FORT LAUDERDALE, Fla., Aug. 18 /- After a lengthy review, The SCOOTER Store, the country's leading provider of power mobility products and services, has selected an integrated Omnicom team as its new agency to help strengthen and broaden the company's brand and messaging. In addition to...

Wound Management Technologies' CellerateRX® Activated Collagenâ„¢ Debuts at the South African Diabetic Foot Working Group Congress in Cape Town

August 18, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, Aug. 18 /- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM ) announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working...

Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs

August 18, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 18 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, today announced that it has entered into an agreement with GVK Biosciences (GVK BIO) to expand the opportunity for...

Advertisement

CROs gain traction from pharma cost cuts

August 13, 2010 1:33 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Parexel International Corp., a Boston-based contract research organization, reported this week that its profit more than doubled in the second quarter year over year. The company is a poster child for the findings in the Global Life Sciences Hiring Index, which found that services and...

Boston Scientific Resolves Corporate Warning Letter

August 11, 2010 11:32 am | by Boston Scientific | News | Comments

NATICK, Mass., Aug. 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in the Company's corporate wa

RXi finding growth in tighter RNAi focus

August 9, 2010 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

In the past few months, RXi Pharmaceuticals Corp. has narrowed its therapeutic focus to eye and skin diseases, won a $600,000 grant from the National Institutes of Health, signed a deal with a global corporate partner and sought to shore up its share price by diversifying its investor portfolio.

Sleep tech firm Zeo wakes up to $1M debt funding

August 9, 2010 5:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Sleep technology company Zeo Inc. of Newton, originally called Axon Labs, has raised $1 million of a planned $1.5 million round of new debt funding.

California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under Medicare

August 6, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

SACRAMENTO, Calif. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across California are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...

Advertisement

Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare

August 6, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

ROCHESTER HILLS, Mich. , Aug. 6 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services across Michigan are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage...

Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010

August 5, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

NEWTON, Mass. , Aug. 5 /- Microfluidics International Corporation (OTC Bulletin Board: MFLU ) announced today the Company will release second quarter 2010 financial results on Tuesday, August 10, 2010 , at 8:30am ET . (Logo: http://photos.prnewswire.com/prnh/20090811/NE59652LOGO )...

In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Ne...

August 5, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass. , Aug. 5 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection (CDI), nearly 70 percent of surveyed infectious disease...

Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results

August 5, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

BEIJING , Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading developer and provider of vaccines in China , announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010...

Genzyme patients call for competitor access to drug patent

August 5, 2010 12:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Three patients taking Genzyme Corp.'s drug for Fabry disease, Fabrazyme, have petitioned the U.S. Department of Health and Human Services to use a rarely-used legal maneuver to open up the drug to competition.

Advertisement

Pascal Metrics Welcomes Jim Conway to Leadership Team as Principal

August 4, 2010 11:38 am | by Bio-Medicine.Org | News | Comments

WASHINGTON , Aug. 4 /- Pascal Metrics is delighted to announce the appointment of Jim Conway as Principal leading its Governance and Leadership Group, effective immediately.  The newly formed Governance & Leadership Group advises boards of directors and senior executive leaders...

Landau Uniforms Donates $600,000 in Scrubs to Haiti Relief

August 4, 2010 11:38 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn. , Aug. 4 /- Landau Uniforms, the nation's leading quality health care apparel manufacturer, has donated more than $600,000 worth of scrubs to aid Haiti relief efforts. "Landau is committed to providing ongoing, long-term support for Haiti as it struggles to recover from...

Health Robotics Continues to Dominate I.V. Automation in America, With 11 New Contracts in Second Quarter 2010

August 4, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BOZEN, SUD-TIROL, Italy , August 4, 2010 /- Health Robotics announced its second consecutive quarter's record-breaking results, as reported by our sales channel partner Health Robotics Canada Inc. (HRCI) since Health Robotics S.r.l. upgraded its American distribution channels this year....

Delcath to Present at the 30th Annual Canaccord Global Growth Conference

August 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , Aug. 4 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that management will present at the 30th Annual Canaccord Global Growth Conference in Boston, MA on Thursday, August 12, 2010 at 8:30 a.m. ET .  Mr. Eamonn Hobbs , Chief Executive Officer, and Mr. David...

Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010

August 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif. , Aug. 4 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2010 , on Tuesday, August 17, 2010 , after the markets close. Cardica's management will host a conference call at...

China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment

August 4, 2010 2:36 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China , Aug. 4 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the State Administration of Foreign...

PerkinElmer acquires imaging tech firm VisEn Medical

August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

PerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.

Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs

August 2, 2010 3:36 am | by Bio-Medicine.Org | News | Comments

THE WOODLANDS, Texas , Aug. 2 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development...

Western European Market for Image-guided and Robot-assisted Surgery

August 2, 2010 1:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK , Aug. 2 /- Reportlinker.com announces that a new market research report is available in its catalogue: Western European Market for Image-guided and Robot-assisted Surgery http://www.reportlinker.com/p0236384/Western-European-Market-for-Image-guided-and-Robot-assist...

Clear CT Scans with Less Radiation

August 1, 2010 8:36 pm | by Massachusetts Institute of Technology | News | Comments

Researchers are devising new ways to get the same results with fewer x-rays.

Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma

July 30, 2010 12:40 pm | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich. , July 30 /- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner...

FDA Approves Vaccines for the 2010-2011 Influenza Season

July 30, 2010 12:40 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States . (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom....

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading